Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 6;14(19):4882.
doi: 10.3390/cancers14194882.

Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer

Affiliations
Review

Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer

Natalia Birknerova et al. Cancers (Basel). .

Abstract

Head and neck cancer (HNC) remains one of the leading causes of mortality worldwide due to tumor diagnosis at a late stage, loco-regional aggression, and distant metastases. A standardized diagnostic procedure for HNC is a tissue biopsy that cannot faithfully portray the in-depth tumor dynamics. Therefore, there is an urgent need to develop simple, accurate, and non-invasive methods for cancer detection and follow-up. A saliva-based liquid biopsy allows convenient, non-invasive, and painless collection of high volumes of this biofluid, with the possibility of repetitive sampling, all enabling real-time monitoring of the disease. No approved clinical test for HNC has yet been established. However, epigenetic changes in saliva circulating cell-free DNA (cfDNA) have the potential for a wide range of clinical applications. Therefore, the aim of this review is to present an overview of cfDNA-based methylation patterns in saliva for early detection of HNC, with particular attention to circulating tumor DNA (ctDNA). Due to advancements in isolation and detection technologies, as well as next- and third-generation sequencing, recent data suggest that salivary biomarkers may be successfully applied for early detection of HNC in the future, but large prospective clinical trials are still warranted.

Keywords: DNA methylation; biomarker; cell-free DNA (cfDNA); circulating tumor DNA (ctDNA); early cancer detection; head and neck cancer; liquid biopsy; saliva.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
General overview of different cancer screening approaches.
Figure 2
Figure 2
Scientific background of PacBio SMRT sequencing.
Figure 3
Figure 3
General depiction of ONT sequencing.

References

    1. International Agency for Research on Cancer Global Cancer Observatory. [(accessed on 24 April 2022)]; Available online: https://gco.iarc.fr/today/home.
    1. Guo K., Xiao W., Chen X., Zhao Z., Lin Y., Chen G. Epidemiological trends of head and neck cancer: A population-based study. BioMed Res. Int. 2021;2021:1738932. doi: 10.1155/2021/1738932. - DOI - PMC - PubMed
    1. Schiff B.A. MSD Manual for the Professional. Available on: Overview of Head and Neck Tumors—Ear, Nose, and Throat Disorders—MSD Manual Professional Edition. [(accessed on 13 April 2022)]. Available online: https://www.msdmanuals.com/professional/ear,-nose,-and-throat-disorders/....
    1. Schutte H.W., Heutink F., Wellenstein D.J., van den Broek G.B., van den Hoogen F.J.A., Marres H.A.M., van Herpen C.M.L., Kaanders J.H.A.M., Merkx T.M.A.W., Takes R.P. Impact of time to diagnosis and treatment in head and neck cancer: A systematic review. Otolaryngol. Head Neck Surg. 2020;162:446–457. doi: 10.1177/0194599820906387. - DOI - PubMed
    1. Lo Nigro C., Denaro N., Merlotti A., Merlano M. Head and neck cancer: Improving outcomes with a multidisciplinary approach. Cancer Manag. Res. 2017;9:363–371. doi: 10.2147/CMAR.S115761. - DOI - PMC - PubMed

LinkOut - more resources